NASDAQ: CNTX - Context Therapeutics Inc.

Yield per half year: -55.36%
Dividend yield: 0%
Sector: Healthcare

Share chart Context Therapeutics Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Context Therapeutics Inc.

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors in the United States. It develops CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-10-20
ISIN US21077P1084
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.contexttherapeutics.com
Цена ао 0.82
Change price per day: 0% (0.75)
Change price per week: -3.97% (0.781)
Change price per month: -13.3% (0.8651)
Change price per 3 month: -8.71% (0.8216)
Change price per half year: -55.36% (1.68)
Change price per year: -62.5% (2)
Change price per 3 year: -48.28% (1.45)
Change price per year to date: -23.47% (0.98)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0.6438 10
P/E 0 0
EV/EBITDA 1.1 10
Total: 5

Efficiency

Title Value Grade
ROA, % -46.81 0
ROE, % -49.89 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0073 10
Total: 8.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 1050.92 10
Yield EPS, % -170.3 0
Total: 4
More

Institutions Volume Share, %
Opaleye Management Inc. 975000 6.11
Ally Bridge Group (NY) LLC 725951 4.55
Vanguard Group Inc 596012 3.73
Affinity Asset Advisors, LLC 328817 2.06
UBS OConnor LLC 296675 1.86
HighTower Advisors, LLC 125852 0.79
Bridgeway Capital Management, Inc. 105809 0.66
Mill Creek Capital Advisors, LLC 104631 0.66
Geode Capital Management, LLC 97240 0.61
Northern Trust Corporation 37219 0.23



Head Job title Payment Year of birth
Mr. Martin A. Lehr Co-Founder, President, CEO & Director 674.08k 1984 (41 year)
Ms. Jennifer Minai-Azary CFO & Treasurer 504.14k 1978 (47 years)
Mr. Alex C. Levit Esq. Chief Legal Officer & Corporate Secretary 483.83k 1979 (46 years)
Mr. Christopher Beck M.B.A. Senior Vice President of Operations N/A
Dr. Claudio Dansky Ullmann M.D. Chief Medical Officer

Address: United States, Philadelphia. PA, 2001 Market Street - open in Google maps, open in Yandex maps
Website: https://www.contexttherapeutics.com